FibroGen, Inc.
PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
Last updated:
Abstract:
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2021
Issue date:
24 Feb 2022